Q3 2024 |
327 |
$3.35B |
+$167M |
-$197M |
-$30.2M |
WSO, AAPL, MSFT, FICO, CPRT
|
13F-HR |
10/24/2024, 08:24 PM |
Q2 2024 |
325 |
$3.14B |
+$71.5M |
-$55.9M |
+$15.6M |
MSFT, WSO, AAPL, FICO, CPRT
|
13F-HR |
7/29/2024, 06:18 PM |
Q1 2024 |
330 |
$3.14B |
+$173M |
-$145M |
+$27.1M |
MSFT, WSO, AAPL, CPRT, FICO
|
13F-HR |
5/10/2024, 12:51 PM |
Q4 2023 |
313 |
$2.96B |
+$53.1M |
-$83.9M |
-$30.8M |
WSO, AAPL, MSFT, FICO, CPRT
|
13F-HR |
2/12/2024, 08:51 PM |
Q3 2023 |
301 |
$2.67B |
+$112M |
-$64.6M |
+$47.1M |
WSO, AAPL, MSFT, CPRT, FICO
|
13F-HR |
11/9/2023, 08:42 AM |
Q2 2023 |
305 |
$2.76B |
+$66.6M |
-$65.9M |
+$630K |
AAPL, WSO, MSFT, CPRT, FICO
|
13F-HR |
8/7/2023, 08:34 AM |
Q1 2023 |
308 |
$2.56B |
+$78.6M |
-$164M |
-$85.1M |
AAPL, WSO, MSFT, CPRT, FICO
|
13F-HR |
5/12/2023, 01:41 PM |
Q4 2022 |
320 |
$2.49B |
+$172M |
-$141M |
+$30.5M |
MSFT, AAPL, WSO, PFE, WRB
|
13F-HR |
1/27/2023, 04:06 PM |
Q3 2022 |
303 |
$2.3B |
+$210M |
-$65.7M |
+$144M |
AAPL, MSFT, WSO, CPRT, WRB
|
13F-HR |
11/9/2022, 08:09 PM |
Q2 2022 |
285 |
$2.32B |
+$113M |
-$55.7M |
+$57.4M |
MSFT, AAPL, WSO, PFE, CPRT
|
13F-HR |
8/8/2022, 03:47 PM |
Q1 2022 |
285 |
$2.63B |
+$243M |
-$97.1M |
+$146M |
MSFT, AAPL, WSO, CPRT, PFE
|
13F-HR |
5/12/2022, 06:34 PM |
Q4 2021 |
262 |
$2.75B |
+$77M |
-$109M |
-$31.6M |
MSFT, AAPL, WSO, CPRT, SHW
|
13F-HR |
2/11/2022, 08:05 AM |
Q3 2021 |
256 |
$2.46B |
+$108M |
-$91.4M |
+$16.9M |
MSFT, AAPL, CPRT, WSO, SHW
|
13F-HR |
11/12/2021, 02:20 PM |
Q2 2021 |
244 |
$2.47B |
+$121M |
-$69M |
+$52.4M |
MSFT, AAPL, WSO, CPRT, SHW
|
13F-HR |
8/3/2021, 04:21 PM |
Q1 2021 |
232 |
$2.27B |
+$91M |
-$61.7M |
+$29.3M |
MSFT, AAPL, WSO, CPRT, SHW
|
13F-HR |
5/7/2021, 09:56 AM |
Q4 2020 |
230 |
$2.2B |
+$64.3M |
-$83.9M |
-$19.6M |
MSFT, AAPL, CPRT, WSO, SHW
|
13F-HR |
2/10/2021, 11:53 AM |
Q3 2020 |
232 |
$2.06B |
+$148M |
-$33.9M |
+$114M |
MSFT, AAPL, WSO, CPRT, SHW
|
13F-HR |
11/12/2020, 10:40 AM |
Q2 2020 |
276 |
$1.86B |
+$97.1M |
-$69.6M |
+$27.5M |
MSFT, AAPL, TYL, WSO, CPRT
|
13F-HR |
8/10/2020, 10:15 AM |
Q1 2020 |
266 |
$1.56B |
+$203M |
-$182M |
+$21.1M |
MSFT, AAPL, TYL, PFE, CCOI
|
13F-HR |
5/5/2020, 11:55 AM |
Q4 2019 |
235 |
$1.82B |
+$88M |
-$150M |
-$61.9M |
MSFT, AAPL, CPRT, PFE, GSIE
|
13F-HR |
2/5/2020, 04:30 PM |
Q3 2019 |
252 |
$1.76B |
+$40.7M |
-$31.2M |
+$9.49M |
MSFT, CPRT, PFE, AAPL, GSIE
|
13F-HR |
11/8/2019, 08:25 AM |
Q2 2019 |
257 |
$1.73B |
+$102M |
-$97.9M |
+$4.24M |
PFE, MSFT, GSIE, CPRT, AAPL
|
13F-HR |
7/24/2019, 08:36 AM |
Q1 2019 |
259 |
$1.64B |
+$117M |
-$102M |
+$14.7M |
PFE, MSFT, AAPL, CPRT, GSIE
|
13F-HR |
4/25/2019, 04:47 PM |
Q4 2018 |
253 |
$1.44B |
+$111M |
-$155M |
-$44M |
PFE, MSFT, AAPL, DGRW, JNJ
|
13F-HR |
1/31/2019, 01:29 PM |
Q3 2018 |
294 |
$1.69B |
+$158M |
-$51.3M |
+$106M |
PFE, MSFT, AAPL, GSIE, DGRW
|
13F-HR |
11/2/2018, 08:26 AM |
Q2 2018 |
262 |
$1.48B |
+$66.3M |
-$92.2M |
-$25.9M |
PFE, MSFT, AAPL, CPRT, DGRW
|
13F-HR |
8/3/2018, 07:33 AM |
Q1 2018 |
266 |
$1.46B |
+$49.3M |
-$72.9M |
-$23.6M |
PFE, MSFT, AAPL, DGRW, JPM
|
13F-HR |
4/25/2018, 09:29 AM |
Q4 2017 |
265 |
$1.49B |
+$56.3M |
-$62.6M |
-$6.3M |
PFE, MSFT, AAPL, DGRW, JNJ
|
13F-HR |
2/5/2018, 12:41 PM |
Q3 2017 |
262 |
$1.41B |
+$57.3M |
-$101M |
-$44M |
PFE, AAPL, MSFT, JNJ, JPM
|
13F-HR |
10/30/2017, 02:33 PM |
Q2 2017 |
273 |
$1.39B |
+$83M |
-$62.4M |
+$20.6M |
PFE, AAPL, MSFT, JNJ, DGRW
|
13F-HR |
7/26/2017, 07:23 PM |
Q1 2017 |
280 |
$1.34B |
+$101M |
-$81.2M |
+$20.2M |
PFE, AAPL, MSFT, JNJ, DGRW
|
13F-HR |
5/11/2017, 03:47 PM |
Q4 2016 |
274 |
$1.27B |
+$124M |
-$96.7M |
+$27.7M |
PFE, MSFT, DGRW, JNJ, AAPL
|
13F-HR |
2/10/2017, 10:43 AM |
Q3 2016 |
260 |
$1.23B |
+$72.7M |
-$88.5M |
-$15.7M |
PFE, JNJ, MSFT, AAPL, GE
|
13F-HR |
11/4/2016, 11:22 AM |
Q2 2016 |
251 |
$1.23B |
+$548M |
-$8.21M |
+$539M |
PFE, JNJ, MSFT, XOM, GE
|
13F-HR |
8/11/2016, 02:46 PM |
Q1 2016 |
175 |
$666M |
+$19.7M |
-$62.4M |
-$42.7M |
PFE, JNJ, XOM, MSFT, CVS
|
13F-HR |
5/2/2016, 06:11 PM |
Q4 2015 |
182 |
$697M |
+$22.5M |
-$66.1M |
-$43.7M |
PFE, JNJ, MSFT, XOM, ABBV
|
13F-HR |
2/2/2016, 03:34 PM |
Q3 2015 |
192 |
$706M |
+$31.4M |
-$45.2M |
-$13.7M |
PFE, JNJ, XOM, AAPL, MSFT
|
13F-HR |
10/29/2015, 07:23 PM |
Q2 2015 |
201 |
$778M |
+$29.4M |
-$34.9M |
-$5.53M |
PFE, AAPL, XOM, ABBV, JNJ
|
13F-HR |
8/6/2015, 05:09 PM |
Q1 2015 |
204 |
$799M |
+$37.3M |
-$30.5M |
+$6.81M |
PFE, XOM, JNJ, AAPL, ABBV
|
13F-HR |
5/15/2015, 12:39 PM |
Q4 2014 |
202 |
$796M |
+$30.6M |
-$28.6M |
+$1.94M |
PFE, XOM, JNJ, ABBV, AAPL
|
13F-HR |
2/18/2015, 10:16 AM |
Q3 2014 |
205 |
$763M |
+$25.4M |
-$19.4M |
+$5.99M |
PFE, XOM, JNJ, ABBV, AAPL
|
13F-HR |
11/5/2014, 03:57 PM |
Q2 2014 |
204 |
$758M |
+$41.3M |
-$35.7M |
+$5.6M |
PFE, XOM, JNJ, ABBV, EMR
|
13F-HR |
8/20/2014, 04:04 PM |
Q1 2014 |
199 |
$747M |
+$47.4M |
-$30.3M |
+$17M |
PFE, XOM, JNJ, ABBV, EMR
|
13F-HR |
5/8/2014, 02:59 PM |
Q4 2013 |
204 |
$729M |
$0 |
$0 |
|
PFE, XOM, ABBV, JNJ, EMR
|
13F-HR |
2/25/2014, 03:36 PM |